Alan Naylor

3.2k citations

72 papers · 2.1k indexed · h-index 24

Pharmacology top 2%
- Inflammatory mediators and NSAID effects 20
Physiology top 2%
Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology 13
Organic Chemistry top 5%
- Asymmetric Synthesis and Catalysis 16
- Synthesis and Biological Evaluation 11
- Synthetic Organic Chemistry Methods 5
Neurology top 5%
Molecular Biology
- Pharmacological Receptor Mechanisms and Effects 8
- Receptor Mechanisms and Signaling 8
- Chemical Synthesis and Analysis 6

Co-authors: Iain P. Chessell Praveen Anand Pascal F. Durrenberger C. Bountra P. Facer Y. Yiangou Stephen G. Davies D. I. C. SCOPES
Cited by: Pharmacology Physiology Cellular and Molecular Neuroscience
Journals: Bioorganic & Medicinal Chemistry Letters (18 papers)Tetrahedron Letters (6 papers)Journal of Medicinal Chemistry (4 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Alan Naylor

71 papers receiving 2.0k citations

Peers

Countries citing papers authored by Alan Naylor

Since Specialization

Citations

This map shows the geographic impact of Alan Naylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Naylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Naylor more than expected).

Fields of papers citing papers by Alan Naylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Naylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Naylor. The network helps show where Alan Naylor may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan Naylor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Naylor Line = papers co-authored together Alan Naylor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma Cancers ·Pan Hu,Barbara Cipriani,Alastair Corbin,David J. Miller,Alan Naylor,Stuart W. Hughes,T. G. McCarthy,Sumeet Ambarkhane,Fahd Hossain,Michael Millward,T Okina,Ignacio Melero	2025	0
2	Phenotypic screening identifies a trisubstituted imidazo[1,2-a]pyridine series that induces differentiation in multiple AML cell lines European Journal of Medicinal Chemistry ·W S Pranowo,Sébastien R. G. Galan,N Mutlu,Thomas Jackson,Tongzhou Qu,Eva Allione,Young-Beom Jeong,Tom S. Carter,Justin T. Lana,Glyn Coxhill,たけし峰,Carole J. R. Bataille,Stephen G. Davies,Paresh Vyas,Thomas A. Milne,Alan Naylor,Graham M. Wynne,Angela J. Russell	2023	5
3	497 PTT-4256 is a first-in-class small molecule inhibitor of GPR65 that counteracts the low pH-dependent immunosuppressive effects on immune cells and displays pronounced anti-tumor activity in mice SHILAP Revista de lepidopterología ·Alastair Corbin,Barbara Cipriani,David Miller,Alan Naylor,Chi Mingming,Н.Н. Романовский,Daniel Kim,Mussa Quareshy,X. Montalban,(unknown),Philip A. MacFaul,Stuart W. Paine,(unknown),Jessica K. Holien,Emmanuel Habarurema,Preeti Singh,喜八郎内田,Maanas Varma SH,Toszka Bohn,Tobias Bopp,弘隆笹岡,Stuart W. Hughes	2023	1
4	PEGylated Biodegradable Polyesters for PGSS Microparticles Formulation: Processability, Physical and Release Properties Current Drug Delivery ·Diego Romano Perinelli,Marco Cespi,Giulia Bonacucina,Alan Naylor,Martin J. Whitaker,Jenny K.W. Lam,Steven M. Howdle,Luca Casettari,Giovanni Filippo Palmieri	2016	8
5	Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process International Journal of Pharmaceutics ·Diego Romano Perinelli,Giulia Bonacucina,Marco Cespi,Alan Naylor,Martin J. Whitaker,Giovanni Filippo Palmieri,Gianfabio Giorgioni,Luca Casettari	2014	24
6	Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology International Journal of Pharmaceutics ·Diana Paola Rojas Perilla,Soo Tee Lim,LG Durrant,Ian Spendlove,Steven M. Howdle,E. F. Fursova,Martin J. Whitaker,Owen R. Davies,Alan Naylor,Andrew L. Lewis,Lisbeth Illum	2011	23
7	Discovery of GSK345931A: An EP1 receptor antagonist with efficacy in preclinical models of inflammatory pain Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Chris Budd,Akm Mahfuzul Haque,Gerard M.P. Giblin,Paul Goldsmith,Thomas G. Hayhow,David N. Hurst,Alan Naylor,Xiong Ke,Tiziana Scoccitti,Mostafa atef,Wendy J. Winchester	2008	23
8	Pyridine-3-carboxamides as novel CB2 agonists for analgesia Bioorganic & Medicinal Chemistry Letters ·William L. Mitchell,Gerard M.P. Giblin,Alan Naylor,Andrew J. Eatherton,Brian P. Slingsby,Sabine Rodriguez-Smith,Karamjit S. Jandu,Carl Haslam,Andrew J. Brown,Paul Goldsmith,Nick M. Clayton,Alex Wilson,Iain P. Chessell,Richard H. Green,Andrew R. Whittington,Ian D. Wall	2008	20
9	Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Andy Billinton,Susan H. Brown,A. R. Chowdhury,Gerard M.P. Giblin,Paul Goldsmith,David N. Hurst,Alan Naylor,Sadhana Patel,Tiziana Scoccitti,Mortaza Mokhtari Nazarlu	2008	23
10	Novel methylene-linked heterocyclic EP1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Rino A. Bit,Susan H. Brown,A. R. Chowdhury,Gerard M.P. Giblin,David N. Hurst,Onize Felicity Ifashe,Xiao Qing Lewell,Alan Naylor,Tiziana Scoccitti	2008	10
11	Discovery of 2-[(2,4-Dichlorophenyl)amino]- N -[(tetrahydro- 2 H -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain Journal of Medicinal Chemistry ·Gerard M.P. Giblin,Celestine T. O’Shaughnessy,Alan Naylor,William L. Mitchell,Andrew J. Eatherton,Brian P. Slingsby,Xiong Ke,Paul Goldsmith,Andrew J. Brown,Carl Haslam,Nick M. Clayton,Alex Wilson,Iain P. Chessell,Guillermina Jacob,Richard Green	2007	109
12	1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists: Structure–activity relationships of 4- and 5-substituted benzoic acid derivatives Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,Akm Mahfuzul Haque,Tanya Coleman,Gerard M.P. Giblin,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,Moobeom Hong,Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,Ots Jamieson	2006	9
13	Structure–activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Stephen J. Atkinson,Susan H. Brown,Iain P. Chessell,A. R. Chowdhury,Akm Mahfuzul Haque,Tanya Coleman,Gerard M.P. Giblin,Robert J. Gleave,Beverley Hammond,Mark P. Healy,Matthew R. Johnson,Anton D. Michel,Alan Naylor,Riccardo Novelli,David J. Spalding,Laurids Jeppe	2006	21
14	Discovery of novel biaryl heterocyclic EP1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Adrian Hall,Rino A. Bit,Susan H. Brown,G. Panariello,Iain P. Chessell,Tanya Coleman,Gerard M.P. Giblin,David N. Hurst,Onize Felicity Ifashe,Xiao Qing Lewell,Anton D. Michel,Jorge Valdez-Carrasco,Alan Naylor,Riccardo Novelli,Cassandra Perry,David J. Spalding,Laurids Jeppe,Richard J. Wilson	2006	16
15	Cyclooxygenase‐2 (Cox‐2) in injured human nerve and a rat model of nerve injury Journal of the Peripheral Nervous System ·Pascal F. Durrenberger,P. Facer,Roy Gray,Iain P. Chessell,Alan Naylor,C. Bountra,Richard B. Banati,Rolfe Birch,Praveen Anand	2004	40
16	Autoradiographic Localisation and Contractile Properties of Prostatic Endothelin Receptors in Patients with Bladder Outlet Obstruction European Urology ·Faiz Mumtaz,Kübra CAN KURT,Kübra CAN KURT,花爱梅,花爱梅,Masood Khan,Alan Naylor,Dimitri P. Mikhailidis,Roger J. Morgan	2001	5
17	4-[(Alkylamino)methyl]furo[3,2-c]pyridines: A New Series of Selective .kappa.-Receptor Agonists Journal of Medicinal Chemistry ·Alan Naylor,Duncan B. Judd,D. I. C. SCOPES,Ann G. Hayes,P.J. Birch	1994	29
18	A potent new class of .kappa.-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines Journal of Medicinal Chemistry ·Alan Naylor,Duncan B. Judd,Arnulfo Soria,D. I. C. SCOPES,Ann G. Hayes,Nabila Hasna Rafilah	1993	83
19	GR94839, a κ‐opioid agonist with limited access to the central nervous system, has antinociceptive activity British Journal of Pharmacology ·H. L. Rogers,P.J. Birch,Susan M. Harrison,J. Seton,Gary R. Manchee,Duncan B. Judd,Alan Naylor,D. I. C. SCOPES,Ann G. Hayes	1992	34
20	A series of novel, highly potent and selective agonists for the κ‐opioid receptor British Journal of Pharmacology ·Ann G. Hayes,P.J. Birch,Neil J. Hayward,Michael J. Sheehan,H. L. Rogers,M.B. Tyers,Duncan B. Judd,D. I. C. SCOPES,Alan Naylor	1990	30

About Alan Naylor

Alan Naylor is a scholar working on Pharmacology, Organic Chemistry, Cellular and Molecular Neuroscience, Structural Biology and Physiology, having authored 72 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (20 papers), Asymmetric Synthesis and Catalysis (16 papers), Neuropeptides and Animal Physiology (13 papers), Synthesis and Biological Evaluation (11 papers), Pharmacological Receptor Mechanisms and Effects (8 papers), Receptor Mechanisms and Signaling (8 papers), Chemical Synthesis and Analysis (6 papers) and Synthetic Organic Chemistry Methods (5 papers). The work is most often cited by research in Pharmacology (551 citations), Physiology (130 citations), Cellular and Molecular Neuroscience (512 citations), Organic Chemistry (683 citations) and Neurology (151 citations). Alan Naylor has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Iain P. Chessell, Praveen Anand, Pascal F. Durrenberger, C. Bountra, P. Facer, Y. Yiangou, Stephen G. Davies, D. I. C. SCOPES, Gerard M.P. Giblin and David Middlemiss. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry, Journal of the Chemical Society Perkin Transactions 1 and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact